These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7055382)

  • 1. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.
    Day CL; Mihm MC; Lew RA; Harris MN; Kopf AW; Fitzpatrick TB; Harrist TJ; Golomb FM; Postel A; Hennessey P; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Rigel D; Friedman RJ; Mintzis MM; Sober AJ
    Ann Surg; 1982 Jan; 195(1):35-43. PubMed ID: 7055382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models.
    Day CL; Lew RA; Mihm MC; Sober AJ; Harris MN; Kopf AW; Fitzpatrick TB; Harrist TJ; Golomb FM; Postel A; Hennessey P; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Rigel D; Friedman RJ; Mintzis MM; Grier RW
    Ann Surg; 1982 Jan; 195(1):44-9. PubMed ID: 7055383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness.
    Harrist TJ; Rigel DS; Day CL; Sober AJ; Lew RA; Rhodes AR; Harris MN; Kopf AW; Friedman RJ; Golomb FM
    Cancer; 1984 May; 53(10):2183-7. PubMed ID: 6704906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.
    Day CL; Sober AJ; Kopf AW; Lew RA; Mihm MC; Hennessey P; Golomb FM; Harris MN; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Postel A; Grier WR; Mintzis MN; Fitzpatrick TB
    Ann Surg; 1981 Apr; 193(4):436-40. PubMed ID: 7212806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.
    Sober AJ; Day CL; Fitzpatrick TB; Lew RA; Kopf AW; Mihm MC
    J Invest Dermatol; 1983 Jun; 80 Suppl():53s-55s. PubMed ID: 6854055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early death from clinical stage I melanoma.
    Sober AJ; Day CL; Fitzpatrick TB; Lew RA; Kopf AW; Mihm MC
    J Invest Dermatol; 1983 Jun; 80 Suppl():50s-52s. PubMed ID: 6854054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of regional lymph nodes in cutaneous melanoma.
    Balch CM
    J Am Acad Dermatol; 1980 Nov; 3(5):511-24. PubMed ID: 7217379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma.
    León P; Daly JM; Synnestvedt M; Schultz DJ; Elder DE; Clark WH
    Arch Surg; 1991 Dec; 126(12):1461-8. PubMed ID: 1842174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.
    Day CL; Mihm MC; Sober AJ; Harris MN; Kopf AW; Fitzpatrick TB; Lew RA; Harrist TJ; Golomb FM; Postel A; Hennessey P; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Rigel D; Friedman RJ; Mintzis MM
    Ann Surg; 1982 Jan; 195(1):30-4. PubMed ID: 7055381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
    White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
    Cole DJ; Baron PL
    Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
    Callery C; Cochran AJ; Roe DJ; Rees W; Nathanson SD; Benedetti JK; Elashoff RM; Morton DL
    Ann Surg; 1982 Jul; 196(1):69-75. PubMed ID: 7092355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.